Variants in frizzled 2 (FZD2), a receptor for the Wnt signalling pathway, are associated with a form of autosomal dominant Robinow Syndrome (AD-RS), a genetic disorder that presents with cleft palate and reduced long bones in the limbs. However, Fzd2-null mice do not recapitulate the limb phenotypes seen in human patients. Now, Rolf Stottmann and colleagues generate new mouse models using CRISPR/Cas9 and i-GONAD editing technologies that precisely model human variants with FZD2-associated AD-RS. By targeting the C-terminal Dishevelled-binding domain of FZD2, the authors generate several alleles that recapitulate cleft palate, limb shortening and perinatal lethality. Consistent with the role of FZD2 in Wnt signalling, the researchers observed that both canonical and non-canonical Wnt signalling activity is reduced using qPCR and by measuring chondrocyte cell length, respectively. Finally, the authors administer IIIC3a (a DKK inhibitor and canonical Wnt signalling agonist) in utero to show that, although embryos still develop a cleft palate, long bones significantly increase in length. Together, these data suggest that activation of canonical Wnt signalling may be sufficient to rescue long bone length in a mouse model of AD-RS and provide a therapeutic strategy for treating short limbs in human FZD2-associated AD-RS patients.
Short-limbs lengthened in mouse models of frizzled 2 variants
- Split-screen
- Views Icon Views
-
Article Versions Icon
Versions
- Version of Record 10 February 2023
- Share Icon Share
-
Tools Icon
Tools
- Search Site
Short-limbs lengthened in mouse models of frizzled 2 variants. Development 1 February 2023; 150 (3): e150_e0304. doi:
Download citation file:
Advertisement
Cited by
Call for papers: Uncovering Developmental Diversity
Development invites you to submit your latest research to our upcoming special issue: Uncovering Developmental Diversity. This issue will be coordinated by our academic Editor Cassandra Extavour (Harvard University, USA) alongside two Guest Editors: Liam Dolan (Gregor Mendel Institute of Molecular Plant Biology, Austria) and Karen Sears (University of California Los Angeles, USA).
Choose Development in 2024
In this Editorial, Development Editor-in-Chief James Briscoe and Executive Editor Katherine Brown explain how you support your community by publishing in Development and how the journal champions serious science, community connections and progressive publishing.
Journal Meeting: From Stem Cells to Human Development
Register now for the 2024 Development Journal Meeting From Stem Cells to Human Development. Early-bird registration deadline: 3 May. Abstract submission deadline: 21 June.
Pluripotency of a founding field: rebranding developmental biology
This collaborative Perspective, the result of a workshop held in 2023, proposes a set of community actions to increase the visibility of the developmental biology field. The authors make recommendations for new funding streams, frameworks for collaborations and mechanisms by which members of the community can promote themselves and their research.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.